Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/19/2026 | Q4 | $7B | -- | -- | $0.38 | -- |
| 10/23/2025 | Q3 | $6.4B | $6.3B | $0.36 | $0.43 | -$0.07 |
| 07/31/2025 | Q2 | $6.2B | $5.9B | $0.24 | $0.32 | -$0.08 |
| 04/24/2025 | Q1 | $6B | $6B | $0.28 | $0.34 | -$0.06 |
| 02/13/2025 | Q4 | $7.2B | $6.6B | $0.30 | $0.31 | -$0.01 |
| 11/07/2024 | Q3 | $6.6B | $5.9B | $0.27 | $0.32 | -$0.05 |
| 07/25/2024 | Q2 | $5.9B | $6B | $0.24 | $0.30 | -$0.06 |
| 04/25/2024 | Q1 | $6.7B | $5.9B | $0.34 | $0.34 | -$0.00 |
| 02/22/2024 | Q4 | $5.7B | $7B | $0.43 | $0.45 | -$0.02 |
| 10/26/2023 | Q3 | $5.5B | $5.9B | $0.16 | $0.25 | -$0.08 |
| 07/27/2023 | Q2 | -- | $5.3B | $0.19 | -- | -- |
| 05/04/2023 | Q1 | -- | $6.2B | $0.27 | -- | -- |
| 02/23/2023 | Q4 | -- | $5.4B | $0.26 | -- | -- |
| 10/27/2022 | Q3 | -- | $5.4B | $0.21 | -- | -- |
| 07/28/2022 | Q2 | -- | $5.1B | $0.17 | -- | -- |
| 04/28/2022 | Q1 | -- | $5.8B | $0.22 | -- | -- |
| 02/10/2022 | Q4 | -- | $5.2B | $0.24 | -- | -- |
| 11/01/2021 | Q3 | -- | $5.5B | -$0.55 | -- | -- |
| 07/29/2021 | Q2 | -- | $5.2B | $0.19 | -- | -- |
| 04/29/2021 | Q1 | -- | $4.7B | $0.06 | -- | -- |
| 02/25/2021 | Q4 | -- | $4.7B | $0.10 | -- | -- |
| 10/29/2020 | Q3 | -- | $4.9B | $0.04 | -- | -- |
| 07/30/2020 | Q2 | -- | $4.5B | -$3.73 | -- | -- |
| 05/01/2020 | Q1 | -- | $4.3B | $0.57 | -- | -- |
| 02/18/2020 | Q4 | -- | $4.7B | -$6.83 | -- | -- |
| 11/07/2019 | Q3 | -- | $4.4B | -$3.06 | -- | -- |
| 07/26/2019 | Q2 | -- | $3.9B | -$4.83 | -- | -- |
| 05/02/2019 | Q1 | -- | $4B | $0.25 | -- | -- |
| 02/28/2019 | Q4 | -- | $4.1B | -$13.24 | -- | -- |
| 11/05/2018 | Q3 | -- | $4.4B | $1.09 | -- | -- |
| 07/26/2018 | Q2 | -- | $4.2B | -$1.91 | -- | -- |
| 05/03/2018 | Q1 | -- | $4.1B | $0.86 | -- | -- |
| 02/09/2018 | Q4 | -- | $4.1B | $0.22 | -- | -- |
| 11/02/2017 | Q3 | -- | $4.5B | $1.07 | -- | -- |
| 07/27/2017 | Q2 | -- | $4.3B | $0.79 | -- | -- |
| 05/02/2017 | Q1 | -- | $4.3B | $1.13 | -- | -- |
| 02/16/2017 | Q4 | -- | $4.7B | $1.36 | -- | -- |
| 11/04/2016 | Q3 | -- | $4.8B | $0.77 | -- | -- |
| 07/28/2016 | Q2 | -- | $4.2B | $0.41 | -- | -- |
| 05/04/2016 | Q1 | -- | $4B | $0.22 | -- | -- |
| 02/18/2016 | Q4 | -- | $4.2B | $0.27 | -- | -- |
PG&E Corp. reported $6.3B worth of top line sales in its most recent quarter.
PG&E Corp. announced earnings per share of $0.36 which represents a miss of analyst forecast a $0.43 per share.
PG&E Corp. reported $1.2B that represents $0.55 per share over the last quarter.
PG&E Corp.'s earnings are forecast to grow from $1.15 per share to $1.36 per share next year representing an increase of 30.08%.
PG&E Corp.'s next earnings date is February 19, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.